K082159

Substantially Equivalent

CIVASTRING PD-103

Applicant: Civatech Oncology, Inc.
Product code: KXK
Advisory panel: Radiology
Date received: 2008-07-31
Decision date: 2008-09-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mebane, NC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.